The direct vasomotor effects of a number of agents used in the therapy of cerebral circulatory and metabolic disease were studied in isolated segments of cat pial vessels in vitro, Studies were repeated eight times gener ally, thus permitting the calculation of the mean maximum response-termed EArn (in dynes)-and of the molar agonist concentration required to effect the half-maximal response, termed EC,o' The results obtained with various agonists were compared to a well-documented vasodilator, acetylcholine (EArn = -780 dyn; EC:;o = 0,029 JLM) and a known vasoconstrictor, 5-hydroxy tryptamine (EArn = + 1630 dyn; EC"o = 0,036 JLM), Papaverine and its deriva tives effected a relaxation of the pial arteries with the following order of po tency: YC-93 > papaverine> naftidrofuryl > viquidiL The EC50 for papaverine was 1,5 JLM, Methyl xanthine derivatives (aminophylline, pentoxifylline, and theophylline) were essentially inactive, In contrast, drugs that are known to be capable of decreasing the volume of an experimental infarction, many of which are described as a-adrenolytic agents, contracted the isolated cerebrovascular smooth muscle, Their order of efficacy, based on the mean EArn values, was ifenprodil > vincamine > nicergoline > dihydroergotoxine > raubasine, In addition, it was considered worthwhile to determine whether the ifenprodil induced vasoconstriction occurred when human, rather than cat, pial vessels were studied, Ifenprodil and vincamine contracted the human vessels in a biphasic manner; the EC,;o was calculated to be 2,0 and 30 JLM, Based on the above observations, the following comments would appear justified, Firstly, an increase in cerebral blood flow does not necessarily mean a compound is a direct vasodilator. Secondly, the vasoconstrictory actions of some agents cor relate well with their anti-ischaemic properties (e,g" ifenprodil, vincamine, and nicergoline), Lastly, one action of effective anti-ischaemic agents might be to reduce flow, by vasoconstriction, in hyperaemic tissue: the inverse "steal" effect. Key Words: In vitro -a-adrenolytic agents-Middle cerebral artery Tension-Cat-Human.
Several pharmacological agents, of widely dif fering structure and profile of activity, are employed in the treatment of cerebrovascular and metabolic diseases. Many of these agents have, however, been criticised as being "direct cerebral vasodilators" and thus may either have no thera-peutic benefit or be theoretically deleterious in some clinical situations such as that of acute, focal cerebral ischaemia (Bartholini et aI., 1980) . However, the putative vasodilatatory properties of these agents have not been well characterized, and we have, accordingly, examined and compared the direct cerebrovascular effects of ifenprodil and other drugs often classified as "cerebral vasodila tators." It has been demonstrated that intravenous administration of various agents used in the treat ment of cerebrovascular disease increase global ce rebral blood flow in the anaesthetised rat (Barry et aI., 1979) . However, one should not assume that these agents have a direct dilatatory action on the cerebrovascular bed solely on the basis of an in crease in cerebral blood flow alone (Young et aI., 1979) . Quite independent from a direct vascular ac tion, many drugs are able to increase cerebral blood flow by an effect that is secondary to an action either on brain metabolism or on electrocortical ac tivity (Edvinsson and MacKenzie, 1976 ). It appears that the direct vascular effects of these anti ischaemic agents have not been previously de scribed. However, it is important to determine whether these agents can directly relax cerebro vascular smooth muscle, because the use of vaso dilator agents in ischaemic brain disease particularly in stroke-has been much criticised. It has been argued that vasodilator, or myolytic, com pounds can result in the intracranial "steal" phe nomenon and, as such, be detrimental in those pa tients with a focal ischaemic lesion (Editorial, 1978; Bartholini et aI., 1980) . In order to exclude all possible metabolic and peripheral effects of these agents, we have chosen to study the intrinsic responses of cerebral vascular smooth muscle to increasing concentrations of the drugs in vitro; a system modified slightly from that described by Edvinsson et aI., (1974) was used. The studies were carried out on segments of the cat middle cerebral artery which were given an active tonic contraction by the addition of prostaglandin F2c< such that either vasodilatatory or vasoconstric tory responses could be identified. For studies in volving human pial vessels, the drugs were tested on arterioles having resting tone alone.
EXPERIMENT AL PROCEDURES

Feline Vessels
Experiments were performed on blood vessels taken from cats of either sex, weighing between 2.0 J Cereb Blood Flow Mecabol, Vol. I, No. I, 1981 and 2.5 kg. The cats were exsanguinated and de capitated under 5% halothane anaesthesia, the brain removed, and the middle cerebral artery immedi ately dissected out and placed in cold Krebs-Ringer buffer solution of the following composition (mM): NaCI, 118; KCI, 4.5; MgS04·2H20, 1.0; KH2P04, 1.0; NaHCO;), 25.0; CaCI2'2H20, 2.5; and glucose 6.0. Small segments (5 mm) of this artery were mounted on two separate systems of L-shaped metal holders (diameter, 0.2 mm) in the same 100 ml organ bath (Fig. 1) . The buffer solution, maintained thermostatically at 37°C, was continuously aerated with a mixture of 95% O2 and 5% CO2 to give a pH of 7.39 ± 0.01.
The L-shaped holders were connected to force-
FIG.1. System for the simultaneous measurement of circular contraction or relaxation in two isolated blood vessels:
isometric force transducer (T), to which, is connected a stainless steel L-shaped metal holder (H); this provides the upper fixation of the vessel, thereby allowing the vessel to be stretched by the use of micromanipulator device (m) for the vertical adjustment of the transducers. Insert shows the sec ond L-shaped holder, fixed to a Perspex base, with the vessel arrangement after mounting: small glass tube (a), ending with a porous stone, to allow the even dispersion of gases used to aerate the buffer solution; inlet and outlet (b) for circulating warm water used to maintain the medium at 37°e , inlet for pre-warmed buffer solution (c), drainage outlet (d).
Note: The diagram shows only one of the two transducers that are used during studies. displacement transducers (Lectromed type 4151) to allow the isometric circular tension of the vessel to be measured. The signals were amplified and re corded on a Lectromed MX 412 potentiometric re corder. Initially, a mechanical load of 400 dyn was applied to the vessels, after which they were al lowed to equilibrate in the bath over a period of 2 h. During this accommodation period, the vessels were rinsed every 15 min with fresh buffer solution, and if necessary, the tension was re-adjusted until a steady level of 400 dyn was reached. Since dilata tory responses were hard to quantify in resting ves sels, the vessels were given an active tonic contrac tion by the addition of prostaglandin Fo: (PGF2o:, 2. 5 /LM). This active contraction not only enhanced any relaxant response that occurred after the adminis tration of the drug under study, but provided us with a clear indication of the condition of the vessel segment after mounting. Vessels which did not re spond to PGF2a were rejected. The contractile ef fect of PGF2a remains constant for about 30 min, i.e. , long enough to test various concentrations of the agent under study. Log concentration-response curves were obtained by the cumulative addition of the agent in concentrations ranging from 0. 1 nM to 100 /LM. Subsequently, calculations were made of the EC;;o value (the concentration of agonist pro ducing half-maximal response) and the EA rn value (the maximal response of the vessel, in dyn).
Human Vessels
Material was obtained from patients undergoing neurosurgical operations for tumours. (Institutional rules governing the protection of human subjects were followed in obtaining and studying these tis sues.) Small pial arteries were removed from macroscopically normal parts of resected brain tis sue. The specimens were transported to the labo ratory in an ice-cold buffer solution as soon as pos sible after removal. Vessel segments (each about 5 mm long and 0. 2-0. 5 mm in diameter) were mounted in a 5 ml temperature-controlled organ bath containing a system of L-formed metal holders for recording isometric circular contractions. The bath and stock solution were maintained at 37°C and aerated continuously with a mixture of 95% O2 and 5% CO2, After the arterial preparation had been mounted in the organ bath, it was subjected to a load of 400 dyn and allowed to stabilise at this level. The test drugs were administered after 1-1 Yz h of equilibra-tion. The effects of agonists were plotted in terms of response against log concentration. The results are generally expressed as mean values ± standard error of the mean.
Materials
The following drugs were extracted or synthe sized by the chemistry department of LERS, by Dr. Tien-Duc, according to the published information: ifenprodil tartrate, midafenone, nicergoline tartrate, pentoxifylline, tinofedrine hydrochloride, vin carnine mesylate, viquidil hydrochloride, and 2,6dimethyl-4-(3-nitrophenyl)-I, 4-dihydropyridine-3, 5-dicarboxylic acid (3-[2-(N-benzyl-N-methyl amino)] ethyl ester 5-methyl ester hydrochloride (YC-93). The drugs were dissolved directly in the bathing medium.
Raubasine hydrochloride was first suspended in Tween 80® before addition to the buffer solution; by itself, Tween had no effect on vascular tone. Naftidrofuryl oxalate was added in its commercial form Praxilene® (Oberval Laboratories), and the vehicle itself (4. 7% sorbitol solution) had no effect on vascular tone. Dihydroergotoxine mesylate is a mixture of the following bases: dihydro-ergocor nine, dihydro-ergocristine, dihydro-a-ergocryptine, and dihydro-f3-ergocryptine (3: 3: 2: 1, respectively). This mixture of ergot alkaloids is available commer cially as Hydergine® (Sandoz), the vehicle of which (a solution containing 5% ethanol and 15% glycerol) had no effect on cerebrovascular smooth muscle when administered at the highest concentration of dihydroergotoxine studied (100 /LM).
The remaining drugs were purchased directly from the manufacturers: acetylcholine chloride, aminophylline [(theophyllineh' ethylenediamine], 5-hydroxytryptamine creatine sulphate, L-nor adrenaline hydrochloride, and theophylline (all from Sigma); and papaverine hydrochloride (Merck). Prostaglandin F2a was added in a commer cial form (Amoglandin®, Astra). Concentrations are expressed in terms of molarities of the base and represent the concentration of drug present in the organ bath. The final molarities of aminophylline are approximate values.
RESULTS
Feline Vessels
Cumulative log concentration-response curves showing changes in tension, induced by increasing concentrations of the agonist under study, are pre sented in Figs. 2-6. The comparative potencies of these agents are represented in Table 1 , with the efficacy of the drugs being summarised in Table 2. In vessel segments, with PGF2(X-induced tone, acetylcholine effected a relaxation on the isolated middle cerebral artery at concentrations ranging from 1. 0 nM to 3. 0 /LM (Fig. 2) , giving an EC;;o = 0.029 /LM (Table 3) .
Papaverine and its analogues all effected a relax ation on the isolated arterial segments with the following order of potency: YC-93 > papaverine> naftidrofuryl > viquidil (Figs. 2 and 3). All of these agents were studied at concentrations between 0. 1 nM and 100 /LM. Papaverine itself, seemed to effect the greatest relaxation, amounting to -1110 dyn, while naftidrofuryl only dilated the vessels by a mean of -610 dyn (Tables 1 and 3) .
The methyl xanthine group (aminophylline, pentoxifylline, and theophylline) failed to exhibit any effect on the pial vessels at concentrations be tween 0. 1 nM and 10 /LM (Fig. 3) . A relaxation was observed, however, only at concentrations in ex cess of 30 /LM. It should be noted that a similar dilatatory effect is observed, at these concentra tions, with drugs that contract cerebrovascular smooth muscle.
In contrast, 5-hydroxytryptamine ( Fig. 4 ) ef fected a strong contraction on the cat middle cere bral artery (+ 1630 dyn) when studied at concentra tions between 1. 0 nM and 1 mM. Unlike vasodi- lators, where the EArn value (the maximal response of the vessel, in dynes) appears to be dependent on the resting tension of the vessel, the cere bral vasoconstrictors which were studied show little relation to the absolute resting tension in the range 400 < resting tension > 1000 dyn. Dihydroergo toxine, nicergoline, raubasine, vincamine, and ifen prodil all effected a contraction on cerebrovascular smooth muscle when studied at increasing concen trations between 0. 1 nM and 100 /LM (Fig. 4) . Nicer goline and raubasine precipitated in the bath at con centrations in excess of 30 /LM. Ifenprodil, vin carnine, and dihydroergotoxine all responded in a biphasic manner; an initial contraction was ob served followed by a relaxation at concentrations> 30 /LM. In terms of potency, the following order would be justified: dihydroergotoxine > nicergoline > raubasine > ifenprodil > vincamine (Table 1) . However, in contrast, the efficacy of these agents would be more correctly expressed as being: ifen prodil > vincamine > nicergoline > dihydroergo toxine > raubasine (Table 2) . Both ifenprodil and vincamine exerted an EArn of> + 1000 dyn (+ 1380 and + 1240 dyn, respectively), whereas dihydro ergotoxine, nicergoline, and raubasine effected slightly weaker contractions amounting to +740, +480, and +650 dyn, respectively.
The effects of some of the contractile agents were also tested on resting arteries. There was no qualitative difference in the contractile responses of these substances as compared with PGF2uactivated vessels. During resting tone (i.e., without PGF2u), ifenprodil and vincamine produced con tractions that were similar to those observed when PGF2a was present. The EC:;o and EArn values were 8.2 ± 1. 7 f.-tM, 1250 ± 140 dyn and 5.4 ± 0.3 f.-tM, 1330 ± 180 dyn for ifenprodil (n = 9) and vincamine (n = 13), respectively. The remaining compounds that were studied can not be readily classified pharmacologically, and al most all of them tended to have effects only at high concentrations. Midafenone (Fig. 5 ) relaxed cere brovascular smooth muscle when studied in vitro, its EC50 value being 5.6 f.-tM. Midafenone is the only compound that is known to be active in acute focal cerebral ischaemia (Tamura et aI., 1979) and that would not appear to constrict cerebral vessels in vitro. Tinofedrine, which has some a-adrenergic properties and is claimed to be beneficial in cerebrovascular disease (Merory et aI., 1978) , has no significant effects on the cerebral vessels when studied in vitro (Fig. 5 ).
Human Vessels
High concentrations of potassium (127 mM) pro duced a strong contraction (520 ± 130 dyn) of the pial vessels examined. Noradrenaline and 5hydroxytryptamine contracted the isolated human pial arterioles in a concentration-dependent manner (in the absence of pharmacological tone). In accor dance with previous findings, the effects of the amines were counteracted by the a-adrenoreceptor blocker, phentolamine, and by the 5-hydroxy tryptamine antagonist, methysergide, respectively. Ifenprodil contracted the human vessels in a biphasic manner (Fig. 6 ), as had been previously observed in feline vessels. The EC:;o value was cal culated to be 2.0 f.-tM (2. 4 f.-tM in feline vessels). Likewise, vincamine contracted the human pial vessels in a concentration-dependent manner (Fig.  6 ). In this instance, the value for the EC50 was found to be 30 f.-tM compared with that of 3. 9 f.-tM in feline vessels. In both instances, at concentrations above 100 f.-tM, a reduced contraction was observed when compared to the preceding dose. The contractile effects of noradrenaline, 5hydroxytryptamine, ifenprodil, and vincamine were, in these tests, roughly 40% of that produced by total depolarization of the cell membrane with high potassium concentration.
DISCUSSION
The object of the present investigation was to characterise the direct cerebrovascular effects of a number of the agents that are currently prescribed for the treatment of various cerebral vascular and metabolic diseases. These agents, reviewed in a number of recent publications (Sathananthan and Gershon, 1975; Yesavage et aI., 1979; Bartholini et aI., 1980) do not form any well-defined pharmacolog ical class or classes. Accordingly, we have at tempted to compare the drugs used in the treatment of cerebrovascular disease with other, better studied compounds such as 5-hydroxytryptamine and acetylcholine (Edvinsson et aI., 1978) . As would be expected, a number of compounds-such as papaverine and its structural derivatives-have been shown capable of effecting a relaxation of 1981 cerebrovascular smooth muscle in the present study; such results would imply that these com pounds could be true cerebral vasodilators when studied in vivo. Other drugs have been shown in the present investigation to be essentially devoid of any direct vasomotor effects; the methyl xanthines Fig. 2 , except for the drugs indicated. EArn (dyn): naftidrofuryl (n = 9), -610 ± 70; aminophylline (n = 7), -560 ± 80; pentoxifylline (n = 6), -680 ± 80; and theophylline (n = 9), -200 ± 80. Values are means ± SEM.
would appear to be representative of this latter class.
More surprisingly, a group of drugs (ifenprodil, dihydroergotoxine, nicergoline, raubasine, and vin carnine) were shown to effect a constriction of the isolated pial vessels; the implication of such a re sponse would be that these compounds are, in vivo, direct cerebral vasoconstrictors (though this pri mary vascular effect might be over-ridden by some other effect, such as a metabolic stimulation).
The results obtained with the human studies demonstrated the contractile effect of noradrena line, 5-hydroxytryptamine, ifenprodil, and vin carnine on isolated human pial arterioles. This ac- tlVlty is roughly 40% of that produced by total depolarization of the cell membrane with high potassium concentrations.
Correlation of Vascular Activity with Other
Pharmacological Effects
There are some important correlations between the drugs that constrict the isolated pial vessels J Cereb Blood Flow Me/abol, Vol. I, No. I. 1981 and their activity in other biological studies. Firstly, with the exception of vincamine, the other constric tor compounds (ifenprodil, dihydroergotoxine, nicergoline, and raubasine) have been described as possessing a-adrenolytic properties in peripheral vascular tissue. Secondly, those compounds that constrict pial vessels have additionally been noted to increase the respiratory efficiency of isolated cerebral mitochondria (Nowicki et aI., unpublished) . Correspondingly, the compounds that relaxed isolated pial vessels were noted either to be in active or to decrease mitochondrial efficiency in the study cited above. The third correlation is that it is the cerebral constrictors that have been noted to reduce the severity and extent of an experimentally induced ischaemic lesion, while, in contrast, the papaverine-like compounds would appear to have no significant beneficial effect in this model of acute, focal ischaemia (Bartholini et al., 1980) .
Relation of Direct Vascular Activity to
Cerebral Blood Flow
In the present investigation we have studied agents which, it is claimed, have a therapeutic ac tion in the treatment of cerebrovascular disease. In parallel studies, it has been shown that many of these agents increased cerebral blood flow in the rat following its intravenous administration ; cerebral blood flow was measured after the administration of ifenprodil, dihydroergotoxine, nicergoline, vincamine, papaverine, YC-93, and naftidrofuryl. However, since the first four of these drugs elicit a vasoconstriction, it is important not to equate an increase in cerebral blood flow with direct cerebral vasodilatation. It is clear that it is not particularly easy to ex trapolate from in vitro studies to the in vivo situa tion, especially that of focal cerebral ischaemia. Many factors could modify the final results, such as J Cereb Blood Flow Metabol, Vol. I, No .. I, 1981 the brain penetration of various drugs and their metabolism, which, in some instances, could take place in the endothelial cells of the cerebral circu lation. Nonetheless, there are very few other possi ble experimental approaches that would allow a classification of the direct vascular actions of these drugs.
One of the reasons for the continued description of drugs that might show some efficacy against the consequences of brain hypoxia as "cerebral vasodilators" is that these agents have often been shown to be capable of effecting an increase in cerebral blood flow. This increase in cerebral perfu sion, demonstrated in various biological models and clinical conditions, has been interpretated as being due to a direct vascular effect. An interpretation of cerebral vasodilatation, based on no more than an increase in cerebral blood flow, is totally fallacious. The brain vasculature is no different from that found in peripheral tissues: blood flow must re spond to the underlying functional and metabolic demands of the parenchyma. Certain drugs might well stimulate brain glycolytic metabolism, nor adrenaline and amphetamine as examples, and thereby effect an increase in cerebral perfusion even though their direct cerebrovascular actions are anything but vasodilatation. This should suffice to show that the description of a drug that increases cerebral blood flow as a "vasodilator" is a sophism; it is essential to show that a drug-induced increase in cerebral blood flow is entirely dissociated from functional and metabolic changes before one can consider direct cerebral vasodilatation as an accu rate explanation of the observed events.
Use of Vasoactive Drugs in Focal
Cerebral Ischaemia
One further criticism of "vasodilators" and their applicability to cerebrovascular disease must be carefully considered. It is more than possible that, when a focal infarct is present, a drug whose only action was that of direct cerebral vasodilatation, could induce a steal phenomenon and could thus exacerbate the neurological consequences of the infarct. Were vessels in the perifocal or penumbral tissue to more effectively dilate than the vessels in the focus of the infarct, then a paradoxical response might ensue whereby the perfusion of the ischaemic tissue was decreased even further. In instances of focal ischaemic disease, there is a real risk of this detrimental response that has been described in brain and in peripheral tissue (Heiss, 1974; Sathananthan and Gershon, 1975; Robinson, 1978; Coffman, 1979) .
However, the use of vasoconstrictors in focal ce rebral ischaemia might have very different implica tions from those described with vasodilators. For example, Depresseux (1978) has shown that the intracarotid administration of vincamine increases the blood flow in the ischaemic foci and reduces blood flow in the hyperaemic regions of cerebro-vascular disease. This "inverse steal phenomenon" has been observed with vincamine and a few related agents in other clinical studies (Herrschaft, 1977; Heiss and Podreka, 1978) . In an experimental study, it has been suggested that the beneficial ef fect of barbiturates in the therapy of focal cerebro vascular disease was as much related to vasocon striction in normal tissue (and thus flow increase in ischaemic tissue) as to the ability of barbiturates to reduce cerebral metabolism (Branston et al., 1979) .
Based on such observations, we would suggest that one important action of vasoconstrictors is to preferentially redistribute blood flow in the is chaemic brain from hyperaemic "luxury-perfused" tissue to the ischaemic focus. This phenomenon, if true, would explain the application of vasocon strictor agents in the therapy of vascular disease. Clearly, such vasoconstriction must be evidenced exclusively or preferentially in the hyperaemic and normal tissue surrounding an infarction, and not in the ischaemic tissue itself.
Vasoconstriction in the ischaemic zone would be most undesirable. However, two characteristics of ischaemic tissue (hypoxia and acidosis) can, when induced in vitro, decrease or abolish the contractile effects of ifenprodil and vincamine (unpublished re sults). These findings would reinforce the hypothe sis that there could be a class of agents that would effect a selective vasoconstriction in normal or hyperaemic brain tissue.
